Atlas Trials

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Clinical trial NCT05992220 · RECRUITING

Trial details

NCT number
NCT05992220
Sponsor
Asan Medical Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular CarcinomaHepatocellular CancerHepatocellular Carcinoma Non-resectableHepatocellular Carcinoma Stage IVLiver Cancer
Start date
2022-10-22
Primary completion
2026-03-01
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.